Barclays’s Lyra Therapeutics LYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Sell |
48
-953
| -95% | – | ﹤0.01% | 4464 |
|
|
2025
Q1 | $6K | Sell |
1,001
-504
| -33% | -$3.02K | ﹤0.01% | 4192 |
|
|
2024
Q4 | $16K | Buy |
1,505
+239
| +19% | +$2.54K | ﹤0.01% | 4136 |
|
|
2024
Q3 | $16K | Buy |
1,266
+934
| +281% | +$11.8K | ﹤0.01% | 4086 |
|
|
2024
Q2 | $4K | Sell |
332
-324
| -49% | -$3.9K | ﹤0.01% | 4050 |
|
|
2024
Q1 | $204K | Hold |
656
| – | – | ﹤0.01% | 3328 |
|
|
2023
Q4 | $172K | Buy |
+656
| New | +$172K | ﹤0.01% | 3562 |
|